EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tumor-associated macrophage-derived exosomes modulate the immunotherapeutic sensitivity of SHH-medulloblastoma by targeting m6A-modified FOXD1

Yantao Liu iD, Yu Peng, Chen Song, Zongran Liu, Xiaolong Yang, Shuqing Bian, Xiaolin Xiao, Haishuang Li, Jing Wang, Ziwen Sun, Xiaodan Liu, Bao Yang und 4 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Yantao Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Research and Transformation of Biomarkers for Neurodegenerative Diseases, Peking University Third Hospital, Peking Universi…. Hauptthemen laut MEDLINE: Forkhead Transcription Factors, Exosomes, Tumor-Associated Macrophages, Medulloblastoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medulloblastoma (MB) is the most common pediatric malignant brain tumor. Infiltration of tumor-associated macrophages (TAMs) and m6A modification of RNA are correlated with poor prognosis and tumor progression in the Sonic Hedgehog (SHH) subtype (SHH-MB). However, the relationship between TAMs infiltration in SHH-MB and m6A modification status during tumor progression remains unclear.

Methods

Expression of m6A modification-related proteins was assessed in 40 cases of SHH-MB. Genes affected by TAM-derived exosomes were identified with methylated RNA immunoprecipitation sequencing. Mechanisms of m6A modification of FOXD1 were evaluated and combinatorial treatment with AAV2/9-shFOXD1 and PD-1 inhibitors was investigated in the NeuroD2:SmoA1 mouse model.

Results

TAMs infiltration led to decreased METTL14 expression, which was mediated by TAM-derived exosomes containing METTL14-specific microRNAs. In turn, this led to lower levels of m6A modifications. Through a screen, FOXD1 was identified as a critical downstream target of TAM-derived exosomes, and its expression level was correlated with poor prognosis in SHH-MBs. Importantly, knockdown of FOXD1 in SHH-MB cells significantly promoted the release of chemokines CXCL10/11, resulting in CD8+ T cell recruitment. Furthermore, treatment with AAV2/9-shFOXD1 significantly enhanced the antitumor effect of the PD-1 inhibitor in transgenic SHH-MB mice.

Conclusions

Our study revealed for the first time that TAM-derived exosomes modulate m6A levels in SHH-MB, which promotes tumor progression via FOXD1. We identified FOXD1 as a novel therapeutic target whose inhibition sensitizes SHH-MB to immune checkpoint blockade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Forkhead Transcription FactorsExosomesTumor-Associated MacrophagesMedulloblastomaImmunotherapyCerebellar NeoplasmsAnimalsHumansMicePrognosisHedgehog ProteinsFemaleMaleTumor Cells, Cultured

Stichwörter der Autor:innen

FOXD1TAMsimmunotherapym6Amedulloblastoma

Substanzen

Forkhead Transcription FactorsFOXD1 protein, humanSHH protein, humanHedgehog Proteins

Autor:innen und Institutionen

  • Beijing Key Laboratory of Research and Transformation of Biomarkers for Neurodegenerative Diseases, Peking University Third Hospital, Peking University Health Science Center, Beijing, China.
  • Department of Neuropathology, Beijing Neurosurgical Institute, Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Pathology, School of Basic Medical Sciences, Peking University Third Hospital, Peking University Health Science Center, Beijing, China.
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Department of Medical Genetics, Center for Medical Genetics, Peking University Health Science Center, Beijing, China.
  • CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.

ORCID-Profile: Yantao Liu, David J H Shih

Förderung

  • Natural Science Foundation

Zitieren

APA

Liu, Y., Peng, Y., Song, C., Liu, Z., Yang, X., Bian, S., Xiao, X., Li, H., Wang, J., Sun, Z., Liu, X., Yang, B., Shih, D. J. H., Luo, J., Liang, H., & Chang, Q. (2025). Tumor-associated macrophage-derived exosomes modulate the immunotherapeutic sensitivity of SHH-medulloblastoma by targeting m6A-modified FOXD1. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf123

Vancouver

Liu Y, Peng Y, Song C, Liu Z, Yang X, Bian S, et al. Tumor-associated macrophage-derived exosomes modulate the immunotherapeutic sensitivity of SHH-medulloblastoma by targeting m6A-modified FOXD1. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf123

BibTeX
@article{Liu2025,
  author = {Liu, Yantao and Peng, Yu and Song, Chen and Liu, Zongran and Yang, Xiaolong and Bian, Shuqing and Xiao, Xiaolin and Li, Haishuang and Wang, Jing and Sun, Ziwen and Liu, Xiaodan and Yang, Bao and Shih, David J H and Luo, Jianyuan and Liang, Hui and Chang, Qing},
  title = {Tumor-associated macrophage-derived exosomes modulate the immunotherapeutic sensitivity of SHH-medulloblastoma by targeting m6A-modified FOXD1},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf123}
}
Kostenlos starten →